Fungal Diastase PCD Pharma Franchise Company
Cafoli Lifecare offers a Fungal Diastase PCD pharma franchise built on 7 formulations across tablets, syrups and drops, all manufactured at WHO-GMP certified facilities. This gives franchise partners a widely used digestive-enzyme line for gastroenterology, paediatrics and general practice.
What is Fungal Diastase?
Fungal diastase is a digestive enzyme (an amylase derived from Aspergillus oryzae) that catalyses the breakdown of dietary starch and complex carbohydrates into simpler, absorbable sugars. It is commonly combined with pepsin to aid the digestion of both carbohydrates and proteins. Read about diastase (amylase) on PubChem.
Therapeutic Applications
Fungal diastase, usually with pepsin, is prescribed for dyspepsia, flatulence, bloating, loss of appetite and other symptoms of impaired carbohydrate and protein digestion, and to support digestion during convalescence. Its tablet, syrup and paediatric drop forms suit all ages. Prescribers include gastroenterologists, paediatricians and general physicians.
Why Fungal Diastase is a High-Potential Molecule for Distributors
Indigestion, bloating and appetite complaints are among the most common everyday presentations across all ages, and enzyme preparations are a high-frequency, OTC-adjacent prescription with strong retail pull. Fungal diastase-pepsin syrups in particular are a staple in paediatric and family practice. That everyday, mass-volume demand makes it a dependable, fast-moving supportive molecule for distributors.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, quality-assured formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- PubChem: Amylase (Diastase)
- PubMed: Fungal Diastase and Pepsin literature
Our formulations of Fungal Diastase find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: